Ligandal, Inc.
PrivateLast Round
Series A
May 1, 2019
Total Funding Raised
$17M
Company Overview
Ligandal, Inc. is a biotechnology company that develops peptide-based delivery technologies for gene therapy, gene editing, and regenerative medicine.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS, Government Contracts
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ligandal, Inc. Comparables
Compare Ligandal, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BreezeBio | 84% | |
| NTrans Technologies | 83% | |
| CyGenica | 82% | |
Ligandal, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 1, 2019 |
Ligandal, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bioverge | Seed |
| Flucas Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2019
$15M round completed.
Ligandal, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ligandal, Inc.'s valuation, stock price, and market status.